Literature DB >> 17072322

IkappaB kinase complexes: gateways to NF-kappaB activation and transcription.

Claus Scheidereit1.   

Abstract

Transcription factors of the NF-kappaB family regulate hundreds of genes in the context of multiple important physiological and pathological processes. NF-kappaB activation depends on phosphorylation-induced proteolysis of inhibitory IkappaB molecules and NF-kappaB precursors by the ubiquitin-proteasome system. Most of the diverse signaling pathways that activate NF-kappaB converge on IkappaB kinases (IKK), which are essential for signal transmission. Many important details of the composition, regulation and biological function of IKK have been revealed in the last years. This review summarizes current aspects of structure and function of the regular stoichiometric components, the regulatory transient protein interactions of IKK and the mechanisms that contribute to its activation, deactivation and homeostasis. Both phosphorylation and ubiquitinatin (destructive as well as non-destructive) are crucial post-translational events in these processes. In addition to controlling induced IkappaB degradation in the cytoplasm and processing of the NF-kappaB precursor p100, nuclear IKK components have been found to act directly at the chromatin level of induced genes and to mediate responses to DNA damage. Finally, IKK is engaged in cross talk with other pathways and confers functions independently of NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17072322     DOI: 10.1038/sj.onc.1209934

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  256 in total

1.  Classical NF-kappaB activation negatively regulates noncanonical NF-kappaB-dependent CXCL12 expression.

Authors:  Lisa A Madge; Michael J May
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

Review 2.  Roles for the ubiquitin-proteasome pathway in protein quality control and signaling in the retina: implications in the pathogenesis of age-related macular degeneration.

Authors:  Fu Shang; Allen Taylor
Journal:  Mol Aspects Med       Date:  2012-04-10

3.  NF-κB in Aging and Disease.

Authors:  Jeremy S Tilstra; Cheryl L Clauson; Laura J Niedernhofer; Paul D Robbins
Journal:  Aging Dis       Date:  2011-12-02       Impact factor: 6.745

4.  NF-κB inhibition delays DNA damage-induced senescence and aging in mice.

Authors:  Jeremy S Tilstra; Andria R Robinson; Jin Wang; Siobhán Q Gregg; Cheryl L Clauson; Daniel P Reay; Luigi A Nasto; Claudette M St Croix; Arvydas Usas; Nam Vo; Johnny Huard; Paula R Clemens; Donna B Stolz; Denis C Guttridge; Simon C Watkins; George A Garinis; Yinsheng Wang; Laura J Niedernhofer; Paul D Robbins
Journal:  J Clin Invest       Date:  2012-06-18       Impact factor: 14.808

5.  Analysis of SRrp86-regulated alternative splicing: control of c-Jun and IκBβ activity.

Authors:  Amanda S Solis; James G Patton
Journal:  RNA Biol       Date:  2010-07-01       Impact factor: 4.652

Review 6.  "Without Ub I am nothing": NEMO as a multifunctional player in ubiquitin-mediated control of NF-kappaB activation.

Authors:  Jérémie Gautheron; Gilles Courtois
Journal:  Cell Mol Life Sci       Date:  2010-05-26       Impact factor: 9.261

Review 7.  Inhibiting NF-κB activation by small molecules as a therapeutic strategy.

Authors:  Subash C Gupta; Chitra Sundaram; Simone Reuter; Bharat B Aggarwal
Journal:  Biochim Biophys Acta       Date:  2010-05-21

8.  Glutaredoxin regulates autocrine and paracrine proinflammatory responses in retinal glial (muller) cells.

Authors:  Melissa D Shelton; Anne M Distler; Timothy S Kern; John J Mieyal
Journal:  J Biol Chem       Date:  2008-12-12       Impact factor: 5.157

9.  A-kinase-anchoring protein-Lbc anchors IκB kinase β to support interleukin-6-mediated cardiomyocyte hypertrophy.

Authors:  Cosmo Damiano del Vescovo; Susanna Cotecchia; Dario Diviani
Journal:  Mol Cell Biol       Date:  2012-10-22       Impact factor: 4.272

10.  MAP30 promotes apoptosis of U251 and U87 cells by suppressing the LGR5 and Wnt/β-catenin signaling pathway, and enhancing Smac expression.

Authors:  Yilin Jiang; Junjie Miao; Dongliang Wang; Jingru Zhou; Bo Liu; Feng Jiao; Jiangfeng Liang; Yangshuo Wang; Cungang Fan; Qingjun Zhang
Journal:  Oncol Lett       Date:  2018-02-16       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.